Details for Patent: 9,925,150

Which drugs does patent 9,925,150 protect, and when does it expire?

Patent 9,925,150 protects NEUPRO and is included in one NDA.

This patent has thirty-two patent family members in twenty-four countries.

Summary for Patent: 9,925,150

Title:	Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
Abstract:	The present invention relates to a method for stabilizing rotigotine, the method comprising providing a solid dispersion comprising polyvinylpyrrolidone and a non-crystalline form of rotigotine, wherein the weight ratio of rotigotine to polyvinylpyrrolidone is in a range from about 9:3.5 to about 9:6. The present invention also relates to a solid dispersion comprising a dispersing agent and a dispersed phase, said dispersed phase comprising rotigotine and polyvinylpyrrolidone, wherein the weight ratio of rotigotine to polyvinylpyrrolidone is in a range from about 9:3.5 to about 9:6, a pharmaceutical composition comprising such a solid dispersion, in particular a transdermal therapeutic system, as well as a method for the preparation thereof.
Inventor(s):	Wolff; Hans-Michael (Monheim, DE), Arth; Christoph (Monheim, DE), Quere; Luc (Braine-l'Alleud, BE), Muller; Walter (Andernach, DE)
Assignee:	LTS Lohmann Therapie-Systeme AG (Andernach, DE) UCB Pharma GmbH (Monheim, DE)
Application Number:	13/515,067
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,925,150
Patent Claim Types: see list of patent claims	Use; Composition; Process;

Drugs Protected by US Patent 9,925,150

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ucb Inc	NEUPRO	rotigotine	FILM, EXTENDED RELEASE;TRANSDERMAL	021829-004	Apr 2, 2012		RX	Yes	No			Y
Ucb Inc	NEUPRO	rotigotine	FILM, EXTENDED RELEASE;TRANSDERMAL	021829-001	May 9, 2007		RX	Yes	Yes			Y
Ucb Inc	NEUPRO	rotigotine	FILM, EXTENDED RELEASE;TRANSDERMAL	021829-005	Apr 2, 2012		RX	Yes	No			Y

Foreign Priority and PCT Information for Patent: 9,925,150

PCT Information
PCT Filed	December 22, 2010	PCT Application Number:	PCT/EP2010/070563
PCT Publication Date:	June 30, 2011	PCT Publication Number:	WO2011/076879

International Family Members for US Patent 9,925,150

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2010334805
Brazil	112012017737
Canada	2767068